Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,298,049
-
Share change
-
-5,968,379
-
Total reported value
-
$12,099,460
-
Price per share
-
$0.91
-
Number of holders
-
30
-
Value change
-
-$16,341,687
-
Number of buys
-
11
-
Number of sells
-
14
Institutional Holders of ATYR PHARMA INC - COM (LIFE) as of Q2 2018
As of 30 Jun 2018,
ATYR PHARMA INC - COM (LIFE) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,298,049 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, Polaris Venture Management Co. V, L.L.C., Viking Global Investors LP, VANGUARD GROUP INC, Alyeska Investment Group, L.P., RENAISSANCE TECHNOLOGIES LLC, Artal Group S.A., BlackRock Inc., and Glen Harbor Capital Management LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.